Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Coherus Oncology, Inc. (CHRS)Equibles does not estimate personal net worth.
Get an email with a short summary when Coherus Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CHRS alertsKerry Graham is recorded as Head of Investor Relations at Coherus Oncology, Inc. (CHRS). Kerry Graham has spoken on 1 earnings call across 1 company, most recently for Coherus Oncology, Inc. on November 9, 2026. Coherus Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coherus Oncology, Inc. includes Dennis Lanfear (CEO), Bryan McMichael (CFO and Chief Accounting Officer), Alan C. Mendelson (Board Member) and 7 others.
“Third Quarter Earnings Conference Calls are Denny Lanfier, Chief Executive Officer of Coharis, Dr. Raj Dias, Chief Medical Officer, Dr. Teresa Lavallee, Chief Scientific and Development Officer, Samira Gorigoker, Chief Commercial Officer, and Brian McMichael, Chief Financial Officer.”
Biotechnology · Healthcare
Head of Investor Relations